• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阑尾癌患者淋巴结转移的预测模型。

A Predictive Model for Nodal Metastases in Patients With Appendiceal Cancers.

机构信息

Division of Surgical Oncology, Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ.

Surgical Outcomes Program, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic Arizona, Phoenix, AZ.

出版信息

Ann Surg. 2021 Jul 1;274(1):155-161. doi: 10.1097/SLA.0000000000003501.

DOI:10.1097/SLA.0000000000003501
PMID:31361626
Abstract

BACKGROUND

Histologic subtypes of appendiceal cancer vary in their propensity for metastases to regional lymph nodes (LN). A predictive model would help direct subsequent surgical therapy.

METHODS

The National Cancer Database was queried for patients with appendiceal cancer undergoing surgery between 1998 and 2012. Multivariable logistic regression was used to develop a predictive model of LN metastases which was internally validated using Brier score and Area under the Curve (AUC).

RESULTS

A total of 21,647 patients were identified, of whom 9079 (41.9%) had node negative disease, 4575 (21.1%) node positive disease, and 7993 (36.9%) unknown LN status. The strongest predictors of LN positivity were histology (carcinoid tumors OR 12.78, 95% CI 9.01-18.12), increasing T Stage (T3 OR 3.36, 95% CI 2.52-4.50, T4 OR 6.30, 95% CI 4.71-8.42), and tumor grade (G3 OR 5.55, 95% CI 4.78-6.45, G4 OR 5.98, 95% CI 4.30-8.31). The coefficients from the regression analysis were used to construct a calculator that generated predicted probabilities of LN metastases given certain inputs. Internal validation of the overall model showed an AUC of 0.75 (95% CI 0.74-0.76) and Brier score of 0.188. Histology-specific predictive models were also constructed with an AUC that varied from 0.669 for signet cell to 0.75 for goblet cell tumors.

CONCLUSIONS

The risk for nodal metastases in patients with appendiceal cancers can be quantified with reasonable accuracy using a predictive model incorporating patient age, sex, tumor histology, T-stage, and grade. This can help inform clinical decision making regarding the need for a right hemicolectomy following appendectomy.

摘要

背景

阑尾癌的组织学亚型在向区域淋巴结(LN)转移的倾向方面存在差异。预测模型将有助于指导后续的手术治疗。

方法

从 1998 年至 2012 年期间接受手术治疗的阑尾癌患者的国家癌症数据库中查询了数据。多变量逻辑回归用于建立 LN 转移的预测模型,并用 Brier 评分和曲线下面积(AUC)进行内部验证。

结果

共确定了 21647 例患者,其中 9079 例(41.9%)为淋巴结阴性疾病,4575 例(21.1%)为淋巴结阳性疾病,7993 例(36.9%)为淋巴结状态未知。LN 阳性的最强预测因素是组织学(类癌肿瘤 OR 12.78,95%CI 9.01-18.12),T 分期增加(T3 OR 3.36,95%CI 2.52-4.50,T4 OR 6.30,95%CI 4.71-8.42)和肿瘤分级(G3 OR 5.55,95%CI 4.78-6.45,G4 OR 5.98,95%CI 4.30-8.31)。回归分析的系数用于构建一个计算器,该计算器根据特定输入生成 LN 转移的预测概率。对整个模型的内部验证显示 AUC 为 0.75(95%CI 0.74-0.76),Brier 评分为 0.188。还构建了组织学特异性预测模型,其 AUC 范围从印戒细胞癌的 0.669 到杯状细胞癌的 0.75。

结论

使用包含患者年龄、性别、肿瘤组织学、T 分期和分级的预测模型,可以合理准确地量化阑尾癌患者的淋巴结转移风险。这有助于为阑尾切除术后是否需要右半结肠切除术提供决策依据。

相似文献

1
A Predictive Model for Nodal Metastases in Patients With Appendiceal Cancers.阑尾癌患者淋巴结转移的预测模型。
Ann Surg. 2021 Jul 1;274(1):155-161. doi: 10.1097/SLA.0000000000003501.
2
A Nomogram for Predicting Lymph Nodal Metastases in Patients with Appendiceal Cancers: An Analysis of SEER Database.基于 SEER 数据库的分析:预测阑尾癌患者淋巴结转移的列线图。
J Invest Surg. 2021 Aug;34(8):924-930. doi: 10.1080/08941939.2019.1711467. Epub 2020 Jan 14.
3
Who should get a right colectomy in low-grade appendiceal adenocarcinomas? Association of lymphovascular invasion and nodal metastases.在低级别阑尾腺癌中,谁应该接受右结肠切除术?淋巴管浸润和淋巴结转移的相关性。
Surgery. 2024 Sep;176(3):560-568. doi: 10.1016/j.surg.2024.05.040. Epub 2024 Jul 9.
4
Predictors of lymph node metastases in patients with mucinous appendiceal adenocarcinoma.黏液性阑尾腺癌患者淋巴结转移的预测因素。
J Surg Oncol. 2020 Sep;122(3):399-406. doi: 10.1002/jso.25963. Epub 2020 Apr 28.
5
Lymph Node Positivity in Appendiceal Adenocarcinoma: Should Size Matter?阑尾腺癌的淋巴结阳性:大小重要吗?
J Am Coll Surg. 2017 Jul;225(1):69-75. doi: 10.1016/j.jamcollsurg.2017.01.056. Epub 2017 Feb 7.
6
Omission of Right Hemicolectomy May be Safe for Some Appendiceal Goblet Cell Adenocarcinomas: A Survival Analysis of the National Cancer Database.某些阑尾杯状细胞腺癌患者可能可以安全地省略右半结肠切除术:国家癌症数据库的生存分析。
Ann Surg Oncol. 2021 Dec;28(13):8916-8925. doi: 10.1245/s10434-021-10191-y. Epub 2021 Aug 18.
7
Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers: A Retrospective Review.淋巴结转移在70例1-3期阑尾癌单中心经验中预测疾病复发:一项回顾性研究。
Ann Surg Oncol. 2015 Oct;22(11):3613-7. doi: 10.1245/s10434-015-4415-5. Epub 2015 Feb 7.
8
Lymph node positivity and association with long-term survival for different histologies of appendiceal cancer.阑尾癌不同组织学类型的淋巴结阳性率与长期生存的关系。
J Surg Oncol. 2021 Jul;124(1):88-96. doi: 10.1002/jso.26493. Epub 2021 Apr 26.
9
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study.对大小为1-2厘米的阑尾神经内分泌肿瘤患者行半结肠切除术与阑尾切除术的比较:一项全欧洲范围的回顾性汇总队列研究。
Lancet Oncol. 2023 Feb;24(2):187-194. doi: 10.1016/S1470-2045(22)00750-1. Epub 2023 Jan 11.
10
Right hemicolectomy for mucinous adenocarcinoma of the appendix: just right or too much?阑尾黏液腺癌行右半结肠切除术:恰到好处还是过度治疗?
Ann Surg Oncol. 2013 Apr;20(4):1063-7. doi: 10.1245/s10434-012-2783-7. Epub 2013 Mar 2.

引用本文的文献

1
Which is the appropriate surgical procedure for appendiceal adenocarcinoma: appendectomy, partial colectomy or right hemicolectomy?阑尾腺癌的合适手术方式是:阑尾切除术、部分结肠切除术还是右半结肠切除术?
Clin Transl Oncol. 2024 Jan;26(1):297-307. doi: 10.1007/s12094-023-03259-6. Epub 2023 Jun 27.
2
Appendectomy Is Oncologically Equivalent to Right Hemicolectomy for Well-Differentiated T1 Appendiceal Adenocarcinoma.阑尾切除术与右半结肠切除术治疗分化良好的 T1 阑尾腺癌的肿瘤学效果相当。
Dis Colon Rectum. 2023 Jan 1;66(1):67-74. doi: 10.1097/DCR.0000000000002089. Epub 2022 Aug 18.